Aegerion is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of severe and rare diseases... Read more
Aegerion is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of severe and rare diseases... Read more
CEO
Add
News
Dec 20, 2019
FinanzNachrichten
Aegerion Pharmaceuticals: Berman Tabacco Announces Client Recovery in $6.5 Million Self-Litigated False Claims Act Settlement Involving Eight Former Executives and Employees of Aegerion Pharmaceuticals, Inc.
Dec 19, 2019
THE IRISH TIMES
Aegerion Pharmaceuticals: Amryt says integration of acquired company 'progressing well'
Sep 25, 2019
FierceBiotechIT
Aegerion Pharmaceuticals: Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Sep 25, 2019
FE Investegate
Aegerion Pharmaceuticals: Amryt Pharma PLC : Completion of Acquisition and $60m equity raised
May 23, 2019
Beckers Hospital Review
Aegerion Pharmaceuticals: Massachusetts pharma company files for bankruptcy
May 21, 2019
4-traders
Aegerion Pharmaceuticals: Cboe Global Markets : Novelion Therapeutics Subsidiary Aegerion Pharmaceuticals to be Acquired by Amryt Pharma Plc Under PFA and RSA
May 21, 2019
Reuters
Aegerion Pharmaceuticals: UK's Amryt Pharma unites lomitapide franchise with Aegerion deal
Feb 07, 2019
Pharmabiz
Aegerion Pharmaceuticals: Recordati to commercialise Aegerion Pharma's rare genetic disease drug Juxtapid in Japan
Aug 01, 2018
The Pharma Letter
Aegerion Pharmaceuticals: New hope for European patients with ultra-rare disease
May 15, 2018
Reuters
Aegerion Pharmaceuticals: Former Aegerion sales rep charged with defrauding U.S. insurers
Aegerion Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10